A Preview Of Teladoc Health's Earnings
Portfolio Pulse from Benzinga Insights
Teladoc Health is set to release its quarterly earnings report on October 30, 2024. Analysts estimate an EPS of $-0.27. The company's past performance has shown a pattern of share price drops following earnings announcements, despite beating EPS estimates. The stock is currently trading at $9.18, down 46.1% over the past year. Analysts have a Neutral rating with a price target of $10.47, indicating a potential 14.05% upside. Teladoc's financial metrics, such as revenue growth and net margin, lag behind industry peers.
October 29, 2024 | 6:02 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Teladoc Health is expected to report an EPS of $-0.27. The stock has a history of price drops post-earnings, despite beating estimates. Analysts rate it Neutral with a $10.47 price target, suggesting a 14.05% upside.
Teladoc Health's upcoming earnings report is crucial as past earnings have led to stock price drops. The Neutral analyst rating and potential upside suggest mixed market sentiment. The company's financial metrics are underperforming compared to peers, which may influence investor expectations.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100